BioSpace News Archive

Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research.

Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces that it has retained Paul Kennedy who will be advising the Company on its commercial growth initiatives.

Provides in-depth scientific and clinical data in R&D event today at 9:00 am ET Outlines data from two completed Phase 1 pharmacokinetic (PK) trials for AQST-108 (dipivefrin) sublingual film Articulates development strategy for second prodrug candidate, AQST-109 sublingual film Provides details on potential patent coverage to at least 2037

Cybin Inc. announces its placement in an editorial published by NetworkNewsWire, one of 50+ trusted brands within the InvestorBrandNetwork, a multifaceted financial news and publishing company for private and public entities.

Align Technology, Inc., makers of the Invisalign® clear aligner system, announced a partnership with U.S. Ski & Snowboard, making the Invisalign brand the Official Smile of U.S. Ski & Snowboard, the Olympic national governing body of ski and snowboard sports in the United States.

$5M cash infusion received in warrant exercises and upfront money from a licensing deal “2020 was a pivotal year for Can-Fite as we demonstrated a robust clinical proof of concept for both Piclidenoson and Namodenoson,” stated Can-Fite CEO Dr. Pnina Fishman

Results From ILLUMINATE-301 To Be Discussed Webinar To Be Held on Wednesday, March 31, 2021 at 12:00 p.m. ET.

NeurOptics, the leader in the science of pupillometry, recently announced that its NPi®-200 pupillometers and the Neurological Pupil Index™ (NPi®) are now being used in the Neurological Intensive Care Unit at Vanderbilt University Medical Center, a highly acclaimed teaching hospital in Nashville, Tenn., as an important measurement for managing patients with brain injury.

Centene Corporation announced that it has partnered with the YWCA USA to deploy Young Women Choosing Action, an innovative program designed to engage 13 to 19-year-old girls from low-income families, especially individuals of color, over the course of three years.

Cipher Pharmaceuticals Inc. announced that it has received approval from the Toronto Stock Exchange to amend its normal course issuer bid in order to enter into an automatic repurchase plan with its designated broker.